160 related articles for article (PubMed ID: 30104275)
1. Nitazoxanide Inhibits Human Norovirus Replication and Synergizes with Ribavirin by Activation of Cellular Antiviral Response.
Dang W; Xu L; Ma B; Chen S; Yin Y; Chang KO; Peppelenbosch MP; Pan Q
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30104275
[TBL] [Abstract][Full Text] [Related]
2. Standardization of an antiviral pipeline for human norovirus in human intestinal enteroids demonstrates nitazoxanide has no to weak antiviral activity.
Lewis MA; Cortés-Penfield NW; Ettayebi K; Patil K; Kaur G; Neill FH; Atmar RL; Ramani S; Estes MK
Antimicrob Agents Chemother; 2023 Oct; 67(10):e0063623. PubMed ID: 37787556
[TBL] [Abstract][Full Text] [Related]
3. Norovirus Replication in Human Intestinal Epithelial Cells Is Restricted by the Interferon-Induced JAK/STAT Signaling Pathway and RNA Polymerase II-Mediated Transcriptional Responses.
Hosmillo M; Chaudhry Y; Nayak K; Sorgeloos F; Koo BK; Merenda A; Lillestol R; Drumright L; Zilbauer M; Goodfellow I
mBio; 2020 Mar; 11(2):. PubMed ID: 32184238
[TBL] [Abstract][Full Text] [Related]
4. Human norovirus cultivation systems and their use in antiviral research.
Hayashi T; Kobayashi S; Hirano J; Murakami K
J Virol; 2024 Apr; 98(4):e0166323. PubMed ID: 38470106
[TBL] [Abstract][Full Text] [Related]
5. Antiviral Effects of Lactococcus lactis on Feline Calicivirus, A Human Norovirus Surrogate.
Aboubakr HA; El-Banna AA; Youssef MM; Al-Sohaimy SA; Goyal SM
Food Environ Virol; 2014 Dec; 6(4):282-9. PubMed ID: 25129102
[TBL] [Abstract][Full Text] [Related]
6. Survival of Human Norovirus Surrogates in Water upon Exposure to Thermal and Non-Thermal Antiviral Treatments.
Zhu S; Barnes C; Bhar S; Hoyeck P; Galbraith AN; Devabhaktuni D; Karst SM; Montazeri N; Jones MK
Viruses; 2020 Apr; 12(4):. PubMed ID: 32325896
[TBL] [Abstract][Full Text] [Related]
7. Anti-norovirus therapeutics: a patent review (2010-2015).
Galasiti Kankanamalage AC; Weerawarna PM; Kim Y; Chang KO; Groutas WC
Expert Opin Ther Pat; 2016; 26(3):297-308. PubMed ID: 26881878
[TBL] [Abstract][Full Text] [Related]
8. Advances in norovirus biology.
Karst SM; Wobus CE; Goodfellow IG; Green KY; Virgin HW
Cell Host Microbe; 2014 Jun; 15(6):668-80. PubMed ID: 24922570
[TBL] [Abstract][Full Text] [Related]
9. Thiazolides, a new class of antiviral agents effective against rotavirus infection, target viral morphogenesis, inhibiting viroplasm formation.
La Frazia S; Ciucci A; Arnoldi F; Coira M; Gianferretti P; Angelini M; Belardo G; Burrone OR; Rossignol JF; Santoro MG
J Virol; 2013 Oct; 87(20):11096-106. PubMed ID: 23926336
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic Suppression of Interferon Lambda Receptor Expression Leads to Enhanced Human Norovirus Replication
Arthur SE; Sorgeloos F; Hosmillo M; Goodfellow IG
mBio; 2019 Oct; 10(5):. PubMed ID: 31575769
[TBL] [Abstract][Full Text] [Related]
11. Progress towards the prevention and treatment of norovirus infections.
Arias A; Emmott E; Vashist S; Goodfellow I
Future Microbiol; 2013 Nov; 8(11):1475-87. PubMed ID: 24199805
[TBL] [Abstract][Full Text] [Related]
12. A robust human norovirus replication model in zebrafish larvae.
Van Dycke J; Ny A; Conceição-Neto N; Maes J; Hosmillo M; Cuvry A; Goodfellow I; Nogueira TC; Verbeken E; Matthijnssens J; de Witte P; Neyts J; Rocha-Pereira J
PLoS Pathog; 2019 Sep; 15(9):e1008009. PubMed ID: 31536612
[TBL] [Abstract][Full Text] [Related]
13. A Standardized Antiviral Pipeline for Human Norovirus in Human Intestinal Enteroids Demonstrates No Antiviral Activity of Nitazoxanide.
Lewis MA; Cortés-Penfield NW; Ettayebi K; Patil K; Kaur G; Neill FH; Atmar RL; Ramani S; Estes MK
bioRxiv; 2023 May; ():. PubMed ID: 37293103
[TBL] [Abstract][Full Text] [Related]
14. Cellular Signaling Analysis shows antiviral, ribavirin-mediated ribosomal signaling modulation.
Ding X; Krutzik PO; Ghaffari AA; Zhaozhi Y; Miranda D; Cheng G; Ho CM; Nolan GP; Sanchez DJ
Antiviral Res; 2019 Nov; 171():104598. PubMed ID: 31513822
[TBL] [Abstract][Full Text] [Related]
15. Treatment of norovirus infections: moving antivirals from the bench to the bedside.
Kaufman SS; Green KY; Korba BE
Antiviral Res; 2014 May; 105():80-91. PubMed ID: 24583027
[TBL] [Abstract][Full Text] [Related]
16. Enteric bacteria promote human and mouse norovirus infection of B cells.
Jones MK; Watanabe M; Zhu S; Graves CL; Keyes LR; Grau KR; Gonzalez-Hernandez MB; Iovine NM; Wobus CE; Vinjé J; Tibbetts SA; Wallet SM; Karst SM
Science; 2014 Nov; 346(6210):755-9. PubMed ID: 25378626
[TBL] [Abstract][Full Text] [Related]
17. Selection and Characterization of Rupintrivir-Resistant Norwalk Virus Replicon Cells
Kitano M; Hosmillo M; Emmott E; Lu J; Goodfellow I
Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29530860
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory Effects of
Kim H; Lim CY; Lee DB; Seok JH; Kim KH; Chung MS
Viruses; 2020 Sep; 12(9):. PubMed ID: 32906822
[TBL] [Abstract][Full Text] [Related]
19. Human Intestinal Enteroids: New Models to Study Gastrointestinal Virus Infections.
Zou WY; Blutt SE; Crawford SE; Ettayebi K; Zeng XL; Saxena K; Ramani S; Karandikar UC; Zachos NC; Estes MK
Methods Mol Biol; 2019; 1576():229-247. PubMed ID: 28361480
[TBL] [Abstract][Full Text] [Related]
20. Bile acids and ceramide overcome the entry restriction for GII.3 human norovirus replication in human intestinal enteroids.
Murakami K; Tenge VR; Karandikar UC; Lin SC; Ramani S; Ettayebi K; Crawford SE; Zeng XL; Neill FH; Ayyar BV; Katayama K; Graham DY; Bieberich E; Atmar RL; Estes MK
Proc Natl Acad Sci U S A; 2020 Jan; 117(3):1700-1710. PubMed ID: 31896578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
